Trupanion CEO Margaret Tooth sells $148,700 in stock

Published 24/03/2025, 23:30
Trupanion CEO Margaret Tooth sells $148,700 in stock

SEATTLE—Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth recently sold 4,000 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The shares were sold on March 20 at a weighted average price of $37.175, totaling approximately $148,700. The transaction comes as Trupanion’s stock has shown strong momentum, delivering a 50.53% return over the past year. According to InvestingPro analysis, the stock is currently trading below its Fair Value. This transaction was executed as part of a previously established Rule 10b5-1 trading plan, which Tooth adopted in November 2024 for financial diversification purposes.

In addition to the stock sale, Tooth exercised stock options to acquire 4,000 shares at an exercise price of $8.93 per share. This transaction amounted to a total value of $35,720. Following these transactions, Tooth holds 118,784 shares of Trupanion common stock.

The sales and acquisitions were conducted with no discretion over the timing, as per the trading plan. The weighted average sale price of the shares was calculated from multiple transactions, with prices ranging from $36.96 to $37.41 per share.

Trupanion is a Seattle-based company specializing in medical insurance for pets, and its shares are traded on the NASDAQ exchange under the ticker symbol TRUP. The $1.64 billion market cap company has achieved 15.97% revenue growth over the last twelve months, and analysts expect the company to turn profitable this year. Get deeper insights and access to 12 additional ProTips with InvestingPro.

In other recent news, Trupanion, Inc. reported its fourth-quarter 2024 earnings, revealing a revenue of $337.3 million, which slightly surpassed analyst forecasts of $335.46 million. However, the company’s earnings per share (EPS) of $0.04 fell short of the projected $0.07, indicating a 42.9% miss. The pet insurance provider also experienced a 19% year-over-year increase in subscription revenue, reaching $227.8 million. Despite some positive financial outcomes, Trupanion’s growth faced challenges, particularly with a slowdown in subscriber growth and retention rates, as noted by analysts from Stifel and Piper Sandler. Stifel revised its price target for Trupanion from $44 to $41, maintaining a Hold rating, while Piper Sandler reduced its target from $57 to $52 but kept an Overweight rating. The company also announced a write-off of $5.3 million in goodwill related to acquisitions in Europe. Trupanion’s guidance for 2025 indicates a cautious outlook, with projected revenue between $1.379 billion and $1.414 billion and subscription revenue growth expected at 14% year-over-year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.